With a newfound understanding of how digital finance and data utility are key sources of crucial business insights, top global pharmaceutical and biotechnology company Pfizer has been building upon a symbiotic partnership with US-based enterprise analytics group MicroStrategy to facilitate cultural innovations in sustainable data accessibility.
Pfizer’s utilization of tools and strategies developed specifically for data analysis has illustrated the value of effectively consolidating and structuring data in order to garner important insights for use among multiple devices, and in both internal and external aspects.
According to Steven Dawson, Pfizer’s Senior Director of Digital Finance, the need to innovate data management and usage was further highlighted once it was determined that different workforce levels benefitted from specific data profiles.
“We realized that there were three very different user personas, the first is the executive leadership team, who need to see very high-level financial data on a monthly basis. The second group we have is the intermediate level of senior leaders, who need to see data for a specific region, perhaps a business unit with a local hierarchy. And then the third group we have is the individual country managers or teams, who need very detailed information and detailed reports,” Dawson explained.
For its part, MicroStrategy acted as the filtration system that ensured the relevant information would be sent to the proper group’s dashboard to promote a culture of seamless data utilization, made stronger by identifying the specific needs of the company.
Additionally, Dawson stated that further enhancement of the system is made possible by taking note of metrics for adoption or non-adoption and understanding the profile of respective dashboard users.
Meanwhile, MicroStrategy President and CFO Phong Le spoke about how the group has used Hyperintelligence to address what was referred to as the “last-mile problem”, by sending crucial data to the appropriate analytical team even at a moment’s notice.
Insights have become more actionable through this and with the addition of business intelligence platforms and programs, data could be utilized in various market areas, strengthening the case for adopting this innovative approach.
Apart from automated financial reporting, MicroStrategy’s plan for digital transformation included a self-serve business intelligence system, enhanced technological intractability and integration, as well as chatbot usage, which were all put to use by Pfizer.
MicroStrategy’s strategy brought forth an unprecedented level of information streamlining by reducing the inter-departmental request traffic, and with Pfizer’s pledge to adopt sustainable data accessibility, the pair’s collaborative efforts have laid the foundation for other, large scale companies to begin innovating efficient data utilization.
